These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37792273)

  • 41. Adrenocorticotropic Hormone in the Treatment of Focal Segmental Glomerulosclerosis Following Kidney Transplantation.
    Grafals M; Sharfuddin A
    Transplant Proc; 2019; 51(6):1831-1837. PubMed ID: 31399168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct effects of HP Acthar Gel on human B lymphocyte activation in vitro.
    Olsen NJ; Decker DA; Higgins P; Becker PM; McAloose CA; Benko AL; Kovacs WJ
    Arthritis Res Ther; 2015 Oct; 17():300. PubMed ID: 26507974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.
    Baughman RP; Barney JB; O'Hare L; Lower EE
    Respir Med; 2016 Jan; 110():66-72. PubMed ID: 26626451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
    Mirsaeidi M; Baughman RP; Sahoo D; Tarau E
    Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy.
    Tumlin J; Galphin C; Santos R; Rovin B
    Kidney Int Rep; 2017 Sep; 2(5):924-932. PubMed ID: 29270498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
    Cusick MF; Libbey JE; Oh L; Jordan S; Fujinami RS
    Autoimmunity; 2015 Jun; 48(4):222-30. PubMed ID: 25410153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroinflammation in Children With Infantile Spasms: A Prospective Study Before and After Treatment With Acthar Gel (Repository Corticotropin Injection).
    Chugani HT; Kumar A
    J Child Neurol; 2020 Oct; 35(12):808-812. PubMed ID: 32576069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population.
    Nazareth T; Datar M; Yu TC
    Neurol Ther; 2019 Dec; 8(2):383-395. PubMed ID: 31564036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenocorticotropic hormone analog use for podocytopathies.
    Filippone EJ; Dopson SJ; Rivers DM; Monk RD; Udani SM; Jafari G; Huang SC; Melhem A; Assioun B; Schmitz PG
    Int Med Case Rep J; 2016; 9():125-33. PubMed ID: 27418857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of Repository Corticotropin Gel (Acthar) in Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: A Report of Three Cases.
    Markell M; Brar A; Bhela S; Patel A; Salifu M
    Kidney Med; 2019; 1(1):31-35. PubMed ID: 32734181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.
    Kaplan J; Miller T; Baker M; Due B; Zhao E
    Front Neurol; 2020; 11():598496. PubMed ID: 33414758
    [No Abstract]   [Full Text] [Related]  

  • 52. Repository Corticotropin Versus Glucocorticoid for Nephrotic Syndrome: When Will We See the Evidence?
    Hartung DM; Johnston K; Deodhar A; Bourdette DN; Cohen DM
    Am J Kidney Dis; 2019 Aug; 74(2):256-262. PubMed ID: 30765104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    Askanase AD; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2020 Dec; 7(4):893-908. PubMed ID: 32996096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders.
    Konen FF; Möhn N; Witte T; Schefzyk M; Wiestler M; Lovric S; Hufendiek K; Schwenkenbecher P; Sühs KW; Friese MA; Klotz L; Pul R; Pawlitzki M; Hagin D; Kleinschnitz C; Meuth SG; Skripuletz T
    Autoimmun Rev; 2023 May; 22(5):103312. PubMed ID: 36924922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repository Corticotropin Injection (Acthar
    Wirta D; McLaurin E; Ousler G; Liu J; Kacmaz RO; Grieco J
    Ophthalmol Ther; 2021 Dec; 10(4):1077-1092. PubMed ID: 34669183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acthar® Gel (repository corticotropin injection) dose-response relationships in an animal model of epileptic spasms.
    Le JT; Frost JD; Swann JW
    Epilepsy Behav; 2021 Mar; 116():107786. PubMed ID: 33548914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
    Rodríguez Mesa XM; Moreno Vergara AF; Contreras Bolaños LA; Guevara Moriones N; Mejía Piñeros AL; Santander González SP
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):196-210. PubMed ID: 34030476
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial.
    Fiechtner JJ; Montroy T
    Lupus; 2014 Aug; 23(9):905-12. PubMed ID: 24795067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse.
    Kaplan J; Miller T; Baker M; Due B; Zhao E
    Neurodegener Dis Manag; 2021 Dec; 11(6):469-476. PubMed ID: 34860120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.